654 results match your criteria: "Yokohama Municipal Citizen's Hospital.[Affiliation]"
Proc Natl Acad Sci U S A
December 2023
Department of Pathology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Infectious virus shedding from individuals infected with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is used to estimate human-to-human transmission risk. Control of SARS-CoV-2 transmission requires identifying the immune correlates that protect infectious virus shedding. Mucosal immunity prevents infection by SARS-CoV-2, which replicates in the respiratory epithelium and spreads rapidly to other hosts.
View Article and Find Full Text PDFCase Rep Oncol
December 2023
Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
JTO Clin Res Rep
December 2023
Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Introduction: Necitumumab plus gemcitabine and cisplatin (GCN) is a standard therapy for patients with advanced lung squamous cell carcinoma (LSqCC). However, the efficacy and tolerability of GCN in second-line or later treatment for patients previously treated with immune checkpoint inhibitors (ICIs) remain unknown.
Methods: This multicenter, retrospective, cohort study assessed the efficacy and tolerability of GCN initiated between November 1, 2019 and March 31, 2022 as second-line to fourth-line treatment in patients with advanced LSqCC who had been pretreated with ICIs.
Endocr J
January 2024
Department of Endocrine Surgery, Kanagawa Cancer Center, Kanagawa 241-8515, Japan.
We analyzed the outcomes of genetic testing to study the frequency of mutations in advanced thyroid cancer in Japan. Patients (n = 96) with unresectable or metastatic thyroid carcinoma were included for retrospective chart review. Results of gene panel testing, which was performed between May 2020 and April 2023, were analyzed.
View Article and Find Full Text PDFWorld J Oncol
December 2023
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Background: With a prevalence of only 1% among all breast cancers in Japan, apocrine carcinoma (AC) is a rare type of breast cancer, and its clinicopathological characteristics remain unclear. The aim of this study was to evaluate the characteristics and prognosis of AC, in relation to the presence or absence of androgen receptor (AR).
Methods: We conducted a retrospective multi-center case-control study (Yokohama Clinical Oncology Group (YCOG): YCOG1701 study) in Japan.
Gland Surg
October 2023
Department of Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Background: Cardiac metastasis from thyroid cancer is rare and has an extremely poor prognosis. Although some patients who undergo heart surgery survive, the therapeutic effectiveness of systemic therapy is limited.
Case Description: A 53-year-old woman with a history of papillary thyroid carcinoma (PTC) presented with cough and right chest discomfort.
Ann Hematol
March 2024
Department of Hematology, Yokohama Municipal Citizen's Hospital, 1-1 Mitsuzawanishi-Cho, Kanagawa-Ku, Yokohama, 221-0855, Japan.
Cancer cachexia is a disorder that affects patient outcomes. The present study prospectively evaluated the prognostic value of the cachexia index (CXI) in elderly patients with non-Hodgkin's lymphoma (NHL). We prospectively analyzed 51 elderly patients who were diagnosed with NHL at our institution.
View Article and Find Full Text PDFBMJ Open
November 2023
Division of Survivorship Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
Introduction: Since May 2019, comprehensive genomic profiling (CGP) has been covered by Japan's health insurance system for patients with solid tumours that have progressed on standard chemotherapy, rare tumours or tumours of unknown primary origin. Although CGP has the potential to identify actionable mutations that can guide the selection of genomically matched therapies for patients with advanced cancer and limited treatment options, less than 10% of patients benefit from CGP testing, which may have a negative impact on patients' mental status. The aim of this study is to investigate the prevalence of psychological distress and associated factors among patients with advanced cancer who are undergoing CGP testing across Japan.
View Article and Find Full Text PDFClin Lung Cancer
January 2024
Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
J Perianesth Nurs
April 2024
Department of Anesthesiology, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Purpose: To elucidate the postgraduation situation of those who have completed a perianesthesia nurse (PAN) educational course offered in master's degree programs in Japan.
Design: This cross-sectional study used an anonymous self-administered questionnaire.
Methods: Of the 42 individuals who completed a PAN educational course offered in master's degree programs in Japan by March 2021, 41 were targeted, excluding the author of this study.
BMC Pulm Med
October 2023
Department of Pathology, School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa, 236-0004, Japan.
Risk factors of severe coronavirus disease 2019 (COVID-19) have been previously reported; however, histological risk factors have not been defined thus far. The aim of this study was to clarify subclinical hidden interstitial lung disease (ILD) as a risk factor of severe pneumonia associated with COVID-19. We carefully examined autopsied lungs and chest computed tomography scanning (CT) images from patients with COVID-19 for interstitial lesions and then analyzed their relationship with disease severity.
View Article and Find Full Text PDFBr J Haematol
February 2024
Department of Hemaology, National Center for Global Health and Medicine, Tokyo, Japan.
J Gastroenterol Hepatol
February 2024
Fukuoka University, Fukuoka, Japan.
J Med Case Rep
October 2023
Departments of Urology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
Chest
October 2023
Departments of Respiratory Medicine, JR Tokyo General Hospital, Tokyo, Japan.
A 33-year-old man presented with a 10-day history of fever, dry cough, and dyspnea. He reported small amounts of frank hemoptysis that occurred several times a day for the past 3 days and a reduction in urine volume. There was no joint pain, skin rash, muscle weakness, or bleeding symptoms, except for the hemoptysis.
View Article and Find Full Text PDFJ Cardiol
February 2024
Department of Cardiology, School of Medicine, Yokohama City University, Yokohama, Japan. Electronic address:
Early mobilization of hospitalized patients is beneficial under certain circumstances. This has been applied in clinical practice for patients with acute heart failure (HF). However, its current definition, effectiveness, and safety are not well established.
View Article and Find Full Text PDFAcute Med Surg
September 2023
Yokohama City Medical Control Council (Yokohama MC) Yokohama Japan.
J Clin Oncol
December 2023
Division of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Medicine (Baltimore)
August 2023
Infection Control and Education Center, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan.
Background: 5-aminolevulinic acid (5-ALA), a natural amino acid that is marketed alongside sodium ferrous citrate (SFC) as a functional food, blocks severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proliferation in vitro and exerts anti-inflammatory effects. In this phase II open-label, prospective, parallel-group, randomized trial, we aimed to evaluate the safety and efficacy of 5-ALA in patients with mild-to-moderate coronavirus disease 2019.
Methods: This trial was conducted in patients receiving 5-ALA/SFC (250/145 mg) orally thrice daily for 7 days, followed by 5-ALA/SFC (150/87 mg) orally thrice daily for 7 days.
PLoS One
August 2023
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Future Oncol
July 2023
Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Eur J Obstet Gynecol Reprod Biol
September 2023
Department Obstetrics and Gynecology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
Objectives: We investigated quality of life (QOL) of patients who underwent total hysterectomy for benign uterine diseases using two surgical approaches: robotic-transvaginal natural orifice transluminal endoscopic surgery (R-vNOTES) and robot-assisted laparoscopic hysterectomy (RALH).
Study Design: This single-center retrospective study was conducted in a tertiary academic setting and included 65 patients who underwent robotic-assisted hysterectomy for benign uterine diseases. Total hysterectomy was performed using R-vNOTES or RALH by the same gynecologist between December 2021 and June 2022.
J Thorac Dis
July 2023
Department of Thoracic Surgery, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan.
Background: Video-assisted thoracoscopic surgery (VATS) is a standard primary spontaneous pneumothorax (PSP) procedure. However, its high recurrence rate compared to open thoracotomy is a problem. Therefore, various methods to prevent recurrence have been developed.
View Article and Find Full Text PDFNihon Shokakibyo Gakkai Zasshi
August 2023
Department of Inflammatory Bowel Disease, Yokohama Municipal Citizen's Hospital.
A 57-year-old man presenting with severe ulcerative colitis (UC) complicated by disseminated intravascular coagulation (DIC) was referred to our hospital. Since it was difficult to improve DIC immediately with any medical treatment, total proctocolectomy, ileoanal canal anastomosis, and ileostomy were performed on the patient. Soon after the surgery, his platelet count and coagulability improved, and he recovered from DIC.
View Article and Find Full Text PDFCancer Med
September 2023
Department of Pulmonology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.